The Research Council has allocated approximately 2.4 MNOK to SoftOx Solutions
AS's subsidiary SoftOx Defense Solutions (SDS) for the completion of a PhD for
the development of a multi-product for the Armed Forces. The PhD program is a
3rd year program in collaboration with the Norwegian Defense Research
Establishment (FFI) and the Department of Pharmacy at the University of Oslo.
The companies will research and develop a multi-product for disinfection and
wound wash, increasing the operational capability of Norwegian soldiers.

- The grant is highly appreciated and it is important for further development of
the project "multiproduct" that The Research Council provides this award, says
CEO of SoftOx Defense Solutions, Rune Jomaas. The PhD candidate is already
active working both at the Norwegian Defense Research Establishment and the
Department of Pharmacy.

For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS, or
CEO Rune Jomaas of SoftOx Defense Solutions AS
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
BioTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange